M
Moderna
Cambridge, United States
Founded 2010 NASDAQ: MRNA
About
Pioneer in mRNA therapeutics using lipid nanoparticle (LNP) delivery technology for vaccines and medicines
Company Details
- Type
- commercial
- Employees
- 1000+
- Funding
- Public
Key Products
- Spikevax COVID-19 Vaccine
- mRNA Platform